A new OECD gold standard for lethal injection drugs
The latest developments in a controversial area of the pharma industry
20th October 2017
Web Exclusives
Harnessing patient communities
Why online communities are so important to both patients and pharma
20th October 2017
Wish you were here?
Why UK expats in former British colonies are not missing the NHS
22nd September 2017
Harnessing predictive analytics
Joseph B. Laudano, vice president, medical affairs strategy for Medmeme, takes a look at advances in data mining and metrics analysis
19th July 2017
Trust in the supply chain
In a world of increasingly complex pharma supply chains, technology is playing a growing role in helping smooth the relationship between businesses and their suppliers
11th July 2017
Pregabalin: the battle continues
A detailed look at the ongoing patent case for Pfizer’s pain drug and what the potentially-landmark ruling could mean for the industry
22nd June 2017
Will there be a Brexit boom?
With Brexit negotiations beginning, Catalyst Corporate Finance’s Tom Cowap argues that Britain's divorce from the EU could actually give a major boost to the UK’s pharma sector
20th June 2017
The wearable revolution
Wearables are here to stay – and pharma shouldn't ignore this golden opportunity
16th June 2017
Why AI won't replace clinical researchers
How technology can help rather than hinder the human touch in clinical research
5th December 2016
Bribery: a bitter pill
What AstraZeneca's bribery scandal says about pharma's compliance policies
10th November 2016
Monsanto-Bayer: a raw deal?
How will Bayer's mega merger with Monsanto affect its pharmaceutical business?
9th November 2016
Previous -- 1 -- Next
